Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Absolute Bioavailability Study of LY3314814 in Healthy Subjects Using an Intravenous Tracer Method

NCT03222427 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03222427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03222427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Absolute Bioavailability Study of LY3314814 in Healthy Subjects Using an Intravenous Tracer Method
Lead sponsor
AstraZeneca
Phase
Phase 1
Overall status
Completed
Start date
January 15, 2018
Completion date
February 16, 2018
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy